---

title: 'Genital Ulcers'
authors:
    - 'Michelle Lin, MD'
created: 2012/05/04
updates: null
categories:
    - 'Infectious Disease'
    - Genitourinary
drugs: null

---



# Genital Ulcers

-   Leading causes in the US: HSV types 1 and 2 (most common) &gt; syphilis &gt; chancroid
-   Note: 10% of chancroid are coinfected with syphilis or HSV

## Differential diagnosis of genital ulcers

<table>
  <tr>
    <th>Infectious (more common)</th>
    <th>Non-infectious (less common)</th>
  </tr>
  <tr>
    <td>
      Genital herpes simple virus (HSV)<br>
      Syphilis<br>
      Chancroid<br>
      Lymphogranuloma venereum<br>
      Granuloma inguinale (donovanosis)<br>
      Fungal infection (eg. candida)<br>
      Secondary bacterial infection
    </td>
    <td>
      Behcet syndrome<br>
      Fixed drug eruption<br>
      Psoriasis<br>
      Sexual trauma<br>
      Wegener granulomatosis
    </td>
  </tr>
</table>

[National Coalition of STD Director Fact Sheets](http://www.ncsddc.org/publications)
From “The Practitioner’s Handbook for the Management of STDs” (4th ed, 2007):

<table>
  <tr>
    <th></th>
    <th>Primary HSV</th>
    <th>Recurrent HSV</th>
    <th>Syphilis</th>
    <th>Chancroid</th>
    <th>LGV</th>
  </tr>
  <tr>
    <td>**Primary lesion**</td>
    <td>Vesicle, papule,ulcers, typically bilateral</td>
    <td>Grouped vesicles, papules, ulcers, typically unilateral  </td>
    <td>Ulcer, papule</td>
    <td>Ulcer, papule</td>
    <td>Papule, pustule, ulcer</td>
  </tr>
  <tr>
    <td>**Border**</td>
    <td>Erythematous,"punched out"  </td>
    <td>Erythematous,"punched out"</td>
    <td>Sharply demarcated </td>
    <td>Violaceous, undermined</td>
    <td>Variable</td>
  </tr>
  <tr>
    <td>**Depth**</td>
    <td>Superficial</td>
    <td>Superficial</td>
    <td>Superficial</td>
    <td>Excavated</td>
    <td>Superficial</td>
  </tr>
  <tr>
    <td>**Base**</td>
    <td>Red and smooth</td>
    <td>Red and smooth</td>
    <td>Red and smooth</td>
    <td>Yellow to gray exudate</td>
    <td>Variable</td>
  </tr>
  <tr>
    <td>**Secretion**</td>
    <td>Serous</td>
    <td>Serous</td>
    <td>Serous</td>
    <td>Purulent to hemorrhagic</td>
    <td>Variable</td>
  </tr>
  <tr>
    <td>**Number of Lesions**</td>
    <td>Bilateral, multiple, extensive lesion may coalesce</td>
    <td>Usually unilateral; labia, penis, scrotum, buttocks, perianal</td>
    <td>Vulva, penis, anal perianal, oral</td>
    <td>Penis, vulva</td>
    <td>Urethra, cervix, rectum</td>
  </tr>
  <tr>
    <td>**Induration**</td>
    <td>None</td>
    <td>None</td>
    <td>Firm</td>
    <td>Rare, usually soft</td>
    <td>None</td>
  </tr>
  <tr>
    <td>**Pain**</td>
    <td>Common</td>
    <td>Common, less severe</td>
    <td>Rare</td>
    <td>Often</td>
    <td>Variable</td>
  </tr>
  <tr>
    <td>**Itching**</td>
    <td>Common</td>
    <td>Common</td>
    <td>Rare</td>
    <td>Rare</td>
    <td>Rare</td>
  </tr>
  <tr>
    <td>**Lymph Nodes**</td>
    <td>Tender, firm, bilateral inguinal adenopathy</td>
    <td>Lymphadenopathy, uncommon, unilateral</td>
    <td>Nontender, firm, enlarged</td>
    <td>Tender, enlarged, may suppurate</td>
    <td>Inguinal and femoral lymphadenopathy: tender, may suppurate</td>
  </tr>
  <tr>
    <td>**Incubation Period**</td>
    <td>2-14 days</td>
    <td>Recurrence within 6-9 months of primary infection </td>
    <td>10-90 days</td>
    <td>1-14 days</td>
    <td>3-21 days</td>
  </tr>
  <tr>
    <td>**Time Course**</td>
    <td>21 days</td>
    <td>7-10 days</td>
    <td>2-3 weeks</td>
    <td>2-3 weeks</td>
    <td>1-2 weeks</td>
  </tr>
  <tr>
    <td>**Diagnostic Test**</td>
    <td>Viral culture</td>
    <td>Viral culture is most sensitive, especially once vesicles rupture and ulcerate. If lesions are granulating, HSV cultures may be negative and HSV serology is useful to confirm etiology.</td>
    <td>Darkfield microscopy, FTA-ABS, VDRL, RPR and DFA-TP</td>
    <td>Culture of *Haemophilus ducreyi*; Gram stain of pus aspirate from lymph node</td>
    <td>Isolation of *Chlamydia trachomatis* from urethra, cervix, rectum or lymph node aspirate; complement fixation serology ≥ 1/64</td>
  </tr>
</table>
## Images 

From *American Family Physician* article![](https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/7/h/64aaee45-534c-5401-8c0b-6f09505268a0/640.png)![](https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/7/h/06cef469-9306-5d8b-9ece-0b9709354e0b/640.png)![](https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/7/h/77104a14-4040-5ecc-9288-eb19aa037c66/640.png)![](https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/7/h/27fa3e29-3ede-5e2b-af8c-481040b5c1f5/640.png)

## References

-   Practitioner’s Handbook (2007)
-   [Roett MA, Mayor MT, Uduhiri KA. Diagnosis and management of genital ulcers. Am Fam Physician. 2012 Feb 1;85(3):254-62.](https://www.ncbi.nlm.nih.gov/pubmed/?term=22335265)
